Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
1112 On Other Exchanges
1112 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

biostime international holdi (1112) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIOSTIME INTERNATIONAL HOLDI (1112)

Related News

No related news articles were found.

biostime international holdi (1112) Related Businessweek News

No Related Businessweek News Found

biostime international holdi (1112) Details

Biostime International Holdings Limited, an investment holding company, provides pediatric nutritional and baby care products to mothers primarily in the People’s Republic of China. The company operates through four segments: Infant Formulas, Probiotic Supplements, Dried Baby Food and Nutrition Supplements, and Baby Care Products. The Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The Dried Baby Food and Nutrition Supplements segment engages in the production of dried baby food products made from natural foods for infants and young children; microencapsulated milk calcium chewable tablets and DHA chews/soft capsules for children, and pregnant and lactating mothers. The Baby Care Products segment provides baby care products for infants and children, including baby diapers and toiletry kits, as well as personal care products for nursing mothers, such as nursing pads. Biostime International Holdings Limited is also involved in the wholesale, retail, import, and export of personal care products for infants; trading of infant food and nutritional products; early childhood education advisory business; and trading of related baby supplies. It sells its products and services through distributors under the Biostime, Adimil, BMcare, and Parenting Power brands. The company was founded in 1999 and is headquartered in Guangzhou, China. Biostime International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.

3,200 Employees
Last Reported Date: 04/1/15
Founded in 1999

biostime international holdi (1112) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: CNY9.1M
Chief Operating Officer and Executive Directo...
Total Annual Compensation: CNY4.5M
Compensation as of Fiscal Year 2014.

biostime international holdi (1112) Key Developments

Biostime International Holdings Limited Recommends Final Dividend for the Year Ended December 31, 2014 Payable on or About June 5, 2015

Biostime International Holdings Limited announced that the board has recommended the payment of a final dividend of HKD 0.41 per ordinary share for the year ended December 31, 2014 against HKD 0.44 per share last year. Taking into account the interim dividend of HKD 0.26 per ordinary share paid in September 2014, the annual dividend for the year ended December 31, 2014 will amount to HKD 0.67 per ordinary share, accounting for approximately 40.0% of profit for the year ended December 31, 2014 against HKD 1.21 per share last year. Subject to the approval of shareholders at the forthcoming annual general meeting to be held on May 15, 2015, the final dividend will be paid on or about June 5, 2015 to the shareholders whose names appear on the register of members of the company on May 27, 2015.

Biostime International Holdings Limited Announces Consolidated Earnings Results for the Year Ended 31 December 2014

Biostime International Holdings Limited announced consolidated earnings results for the year ended 31 December 2014. For the year, the company reported revenue was RMB 4,731,563,000 against RMB 4,561,299,000 a year ago. Profit before tax was RMB 1,118,335,000 against RMB 1,162,096,000 a year ago. Profit attributable to owners of the parent was RMB 806,786,000 against RMB 820,715,000 a year ago. Diluted earnings per share were RMB 1.31 against RMB 1.34 a year ago. Capital expenditure was RMB 197,089,000 against RMB 430,200,000 a year ago. Net cash flows from operating activities amounted to RMB 972.2 million, representing an increase of RMB 311.7 million or 47.2% from RMB 660.5 million in 2013. The increase in revenue was mainly attributable to the growth of Adimil, the group's new brand of infant formulas launched in late 2013.

Biostime International Holdings Limited (China) to Report Fiscal Year 2014 Results on Mar 24, 2015

Biostime International Holdings Limited (China) announced that they will report fiscal year 2014 results on Mar 24, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1112:HK $35.15 HKD -0.45

1112 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 3,993 INR +52.55
Inner Mongolia Yili Industrial Group Co Ltd CNY36.88 CNY +0.42
Mead Johnson Nutrition Co $96.25 USD +0.33
Synutra International Inc $7.02 USD -0.24
Yakult Honsha Co Ltd ¥7,430 JPY -100.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 1112 Industry Range
Price/Earnings 21.7x
Price/Sales 3.6x
Price/Book 5.9x
Price/Cash Flow 21.4x
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOSTIME INTERNATIONAL HOLDI, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at